Ozempic maker cuts brand-name price as generic semaglutide hits pharmacy shelves
The price of Ozempic, a leading diabetes and weight loss medication in Canada, is decreasing as generic versions of its active ingredient, semaglutide, become available. Apotex Inc. has launched a generic version priced significantly lower than the brand-name product. Novo Nordisk, the maker of Ozempic, is also introducing discounts for uninsured patients to match the generic prices.
- ▪Ozempic's price is dropping due to the introduction of generic semaglutide.
- ▪Apotex's generic version is priced at $78.14 for a four-week supply, compared to $240.48 for the brand-name Ozempic.
- ▪Novo Nordisk will offer discount cards for uninsured patients to access Ozempic at generic prices.
Opening excerpt (first ~120 words) tap to expand
Open this photo in gallery:Boxes of semaglutide injection pens at a pharmacy in Oshawa last October.EDUARDO LIMA/The Globe and MailShareSave for laterPlease log in to bookmark this story.Log InCreate Free AccountThe price of Canada’s best-selling drug, Ozempic, is starting to plummet.Generic forms of semaglutide, the active ingredient in Ozempic, have begun to hit pharmacy shelves. The first product widely available is from Toronto-headquartered Apotex Inc., which is pricing its version of Ozempic at less than a third of the cost of the brand name.Meanwhile, Danish drug manufacturer Novo Nordisk NVO-N, the maker of Ozempic, announced Tuesday it would start offering discounts to patients not covered by insurance so they could pay the generic price for the brand-name product.Semaglutide…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Globe and Mail.
Discussion
0 commentsMore from The Globe and Mail
